The Editors of Prostate Cancer and Prostatic Diseases (PCAN) are proud to present a special collection on “Disparities in Prostate Cancer Diagnosis and Management”. The collection features papers from ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

Obesity and prostate cancer are two very common diagnoses in older men, and several studies have found a relationship between excess weight and prostate cancer progression. “The diagnosis of cancer is ...

As a physician, researcher, and biotech leader with personal experience of prostate cancer in my family, I’ve long advocated for putting patients first in our quest for medical innovation. Today, I ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Changes in planned disease management after piflufolastat F18 PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study. This ...

SIR Cliff Richard has backed calls for a prostate cancer national screening test for men, and wants King Charles to raise ...

Results of a cross-sectional survey to explore determinants of health-promoting activities among Hispanic/Latino (H/L) patients (pts) with prostate cancer (PCa) on androgen deprivation therapy (ADT).

Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish(R) Water Vapor Ablation System for the management of prostate cancer, today announced that the U.S.

Health experts urge men to prioritize early prostate cancer screening. Learn about the major risk factors, lifestyle choices, ...